Literature DB >> 15824248

It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE study.

Ingrid U Scott, Michael S Ip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15824248     DOI： 10.1001/archopht.123.4.581

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  2 in total

1.  Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.

Authors:  M Elizabeth Hartnett; David J Martiniuk; Yuta Saito; Pete Geisen; Lynda J Peterson; Janet R McColm
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

2.  SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.

Authors:  Clement K Chan; Michael S Ip; Paul C Vanveldhuisen; Neal L Oden; Ingrid U Scott; Michael J Tolentino; Barbara A Blodi
Journal:  Ophthalmology       Date:  2011-03-26       Impact factor: 12.079
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.